| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,148 |
5,783 |
$1.07M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,414 |
5,941 |
$1.04M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,031 |
2,153 |
$899K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,688 |
2,503 |
$741K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,108 |
3,879 |
$682K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,542 |
1,498 |
$415K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,290 |
1,252 |
$343K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,534 |
1,489 |
$242K |
| 80053 |
Comprehensive metabolic panel |
9,197 |
8,128 |
$216K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
944 |
928 |
$210K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,975 |
1,395 |
$171K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
813 |
741 |
$161K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,500 |
3,385 |
$155K |
| G0378 |
Hospital observation service, per hour |
284 |
246 |
$115K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,221 |
1,155 |
$54K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
772 |
772 |
$49K |
| 97161 |
|
329 |
326 |
$46K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
168 |
162 |
$44K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
291 |
288 |
$23K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,607 |
1,488 |
$21K |
| 86850 |
|
436 |
422 |
$19K |
| 86901 |
|
436 |
422 |
$15K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,446 |
3,058 |
$14K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
334 |
118 |
$13K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
499 |
122 |
$12K |
| 85610 |
|
2,983 |
2,818 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
2,049 |
1,502 |
$11K |
| 83880 |
|
373 |
352 |
$11K |
| 86900 |
|
437 |
422 |
$10K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
82 |
81 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
1,065 |
1,048 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
266 |
229 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
306 |
255 |
$6K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
24 |
24 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,787 |
6,660 |
$6K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,060 |
1,986 |
$6K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
26 |
26 |
$5K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
768 |
768 |
$5K |
| 12001 |
|
13 |
13 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
34 |
29 |
$5K |
| 99406 |
|
237 |
227 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,354 |
2,101 |
$4K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
35 |
35 |
$3K |
| 71045 |
Radiologic examination, chest; single view |
2,964 |
2,824 |
$3K |
| 76641 |
|
120 |
118 |
$3K |
| 97162 |
|
14 |
14 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,909 |
3,351 |
$2K |
| 93971 |
|
13 |
12 |
$2K |
| 84466 |
|
145 |
136 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
59 |
59 |
$2K |
| 82728 |
|
117 |
111 |
$1K |
| 83735 |
|
2,297 |
1,992 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
245 |
235 |
$960.05 |
| 81025 |
|
288 |
279 |
$937.96 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
180 |
150 |
$932.16 |
| 84484 |
|
2,718 |
2,314 |
$867.26 |
| 88304 |
|
12 |
12 |
$832.48 |
| 80320 |
|
1,051 |
990 |
$665.90 |
| 83540 |
|
144 |
136 |
$642.41 |
| 81001 |
|
2,536 |
2,376 |
$637.79 |
| 83605 |
|
1,047 |
869 |
$521.51 |
| 85730 |
|
1,144 |
1,091 |
$455.57 |
| 83690 |
|
2,221 |
2,081 |
$402.52 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,382 |
1,320 |
$400.07 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
13 |
12 |
$366.97 |
| 84100 |
|
258 |
234 |
$319.24 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,289 |
2,042 |
$271.63 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,769 |
1,655 |
$266.69 |
| 84703 |
|
2,111 |
1,996 |
$262.81 |
| 82607 |
|
29 |
26 |
$262.08 |
| 82746 |
|
27 |
24 |
$251.03 |
| 82948 |
|
1,200 |
666 |
$242.21 |
| 76830 |
Ultrasound, transvaginal |
13 |
12 |
$242.17 |
| 87400 |
|
1,857 |
1,709 |
$232.10 |
| 87468 |
|
12 |
12 |
$183.54 |
| 87484 |
|
12 |
12 |
$183.54 |
| 82947 |
|
603 |
410 |
$176.14 |
| 81003 |
|
1,746 |
1,693 |
$167.28 |
| 87040 |
|
436 |
259 |
$147.66 |
| 96376 |
|
125 |
118 |
$144.22 |
| 85379 |
|
309 |
301 |
$139.02 |
| J2704 |
Injection, propofol, 10 mg |
1,436 |
1,395 |
$134.89 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,735 |
2,537 |
$130.43 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,635 |
2,369 |
$118.36 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
406 |
392 |
$102.80 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
713 |
658 |
$100.87 |
| 87420 |
|
238 |
236 |
$70.81 |
| 85027 |
|
64 |
56 |
$59.36 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,186 |
1,140 |
$54.66 |
| 73130 |
|
12 |
12 |
$42.26 |
| 94761 |
|
157 |
152 |
$39.61 |
| 73630 |
|
12 |
12 |
$36.67 |
| 73610 |
|
14 |
14 |
$32.83 |
| 72100 |
|
14 |
14 |
$29.70 |
| 85007 |
|
49 |
42 |
$28.46 |
| 87430 |
|
345 |
342 |
$27.62 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,101 |
1,072 |
$27.21 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
68 |
57 |
$19.76 |
| 87081 |
|
283 |
281 |
$16.80 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
151 |
129 |
$12.54 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,013 |
975 |
$10.13 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
49 |
36 |
$9.58 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
17 |
12 |
$7.52 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
172 |
141 |
$6.92 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
93 |
92 |
$4.40 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
526 |
518 |
$2.30 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
54 |
53 |
$0.47 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
83 |
78 |
$0.37 |
| A4649 |
Surgical supply; miscellaneous |
43 |
42 |
$0.00 |
| 86618 |
|
16 |
15 |
$0.00 |
| 80329 |
|
777 |
446 |
$0.00 |
| 87077 |
|
13 |
13 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
19 |
15 |
$0.00 |